dapagliflozin/semaglutide (NN9917)
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 05, 2026
The REVERT-PREDIABETES trial
(clinicaltrialsregister.eu)
- P3/4 | N=158 | Recruiting | Sponsor: Region Midtjylland | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Coronary Artery Disease • Metabolic Disorders
August 09, 2023
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
(clinicaltrials.gov)
- P1 | N=152 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed
Trial completion
July 13, 2022
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
(clinicaltrials.gov)
- P1 | N=138 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open
1 to 3
Of
3
Go to page
1